nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotaxime—SLC22A7—Fluorouracil—breast cancer	0.143	0.289	CbGbCtD
Cefotaxime—SLC22A7—Docetaxel—breast cancer	0.109	0.22	CbGbCtD
Cefotaxime—SLC22A11—Methotrexate—breast cancer	0.0829	0.167	CbGbCtD
Cefotaxime—SLC22A7—Methotrexate—breast cancer	0.079	0.159	CbGbCtD
Cefotaxime—SLC22A8—Methotrexate—breast cancer	0.0482	0.0972	CbGbCtD
Cefotaxime—SLC22A6—Methotrexate—breast cancer	0.0336	0.0677	CbGbCtD
Cefotaxime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A7—breast cancer	0.00127	0.0123	CbGpPWpGaD
Cefotaxime—SLC22A7—Fluoropyrimidine Activity—DPYD—breast cancer	0.00124	0.0121	CbGpPWpGaD
Cefotaxime—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A7—breast cancer	0.0012	0.0117	CbGpPWpGaD
Cefotaxime—SLC22A7—Fluoropyrimidine Activity—ABCG2—breast cancer	0.00116	0.0112	CbGpPWpGaD
Cefotaxime—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A10—breast cancer	0.00111	0.0108	CbGpPWpGaD
Cefotaxime—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—breast cancer	0.0011	0.0107	CbGpPWpGaD
Cefotaxime—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A7—breast cancer	0.00109	0.0106	CbGpPWpGaD
Cefotaxime—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A5—breast cancer	0.00106	0.0103	CbGpPWpGaD
Cefotaxime—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—breast cancer	0.000999	0.00971	CbGpPWpGaD
Cefotaxime—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A5—breast cancer	0.000961	0.00934	CbGpPWpGaD
Cefotaxime—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A10—breast cancer	0.000924	0.00898	CbGpPWpGaD
Cefotaxime—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A7—breast cancer	0.000918	0.00892	CbGpPWpGaD
Cefotaxime—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—breast cancer	0.000912	0.00886	CbGpPWpGaD
Cefotaxime—SLC22A7—Fluoropyrimidine Activity—SMUG1—breast cancer	0.000885	0.0086	CbGpPWpGaD
Cefotaxime—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—breast cancer	0.000839	0.00816	CbGpPWpGaD
Cefotaxime—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—breast cancer	0.000827	0.00804	CbGpPWpGaD
Cefotaxime—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A5—breast cancer	0.000808	0.00785	CbGpPWpGaD
Cefotaxime—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A7—breast cancer	0.000766	0.00744	CbGpPWpGaD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.000721	0.00701	CbGpPWpGaD
Cefotaxime—SLC22A7—Fluoropyrimidine Activity—TYMS—breast cancer	0.000708	0.00688	CbGpPWpGaD
Cefotaxime—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—breast cancer	0.000702	0.00682	CbGpPWpGaD
Cefotaxime—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—breast cancer	0.000701	0.00681	CbGpPWpGaD
Cefotaxime—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—breast cancer	0.000695	0.00676	CbGpPWpGaD
Cefotaxime—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A5—breast cancer	0.000674	0.00655	CbGpPWpGaD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.000667	0.00648	CbGpPWpGaD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.00066	0.00641	CbGpPWpGaD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.00066	0.00641	CbGpPWpGaD
Cefotaxime—SLC22A7—Fluoropyrimidine Activity—ERCC2—breast cancer	0.000658	0.0064	CbGpPWpGaD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.000655	0.00636	CbGpPWpGaD
Cefotaxime—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—breast cancer	0.000651	0.00633	CbGpPWpGaD
Cefotaxime—SLC22A7—Fluoropyrimidine Activity—MTHFR—breast cancer	0.000619	0.00601	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.000619	0.00601	CbGpPWpGaD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.00061	0.00593	CbGpPWpGaD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.00061	0.00593	CbGpPWpGaD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.000599	0.00582	CbGpPWpGaD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.000599	0.00582	CbGpPWpGaD
Cefotaxime—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—breast cancer	0.00058	0.00564	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.000566	0.0055	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.000566	0.0055	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.00055	0.00535	CbGpPWpGaD
Cefotaxime—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—breast cancer	0.000549	0.00533	CbGpPWpGaD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000547	0.00531	CbGpPWpGaD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000505	0.00491	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.000503	0.00489	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.000503	0.00489	CbGpPWpGaD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.0005	0.00486	CbGpPWpGaD
Cefotaxime—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—breast cancer	0.000498	0.00484	CbGpPWpGaD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000496	0.00482	CbGpPWpGaD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000481	0.00468	CbGpPWpGaD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000481	0.00468	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000469	0.00456	CbGpPWpGaD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000462	0.00449	CbGpPWpGaD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.000459	0.00446	CbGpPWpGaD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000454	0.00441	CbGpPWpGaD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000445	0.00432	CbGpPWpGaD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000445	0.00432	CbGpPWpGaD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000437	0.00425	CbGpPWpGaD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000437	0.00425	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000429	0.00417	CbGpPWpGaD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.00042	0.00408	CbGpPWpGaD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.00042	0.00408	CbGpPWpGaD
Cefotaxime—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—breast cancer	0.000418	0.00407	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000417	0.00405	CbGpPWpGaD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000414	0.00403	CbGpPWpGaD
Cefotaxime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—breast cancer	0.000413	0.00402	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000413	0.00401	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000413	0.00401	CbGpPWpGaD
Cefotaxime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—breast cancer	0.000384	0.00373	CbGpPWpGaD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000383	0.00372	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000381	0.00371	CbGpPWpGaD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000376	0.00365	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000367	0.00357	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000367	0.00357	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000367	0.00356	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000355	0.00345	CbGpPWpGaD
Cefotaxime—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—breast cancer	0.000349	0.00339	CbGpPWpGaD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000348	0.00338	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000339	0.00329	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000335	0.00326	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000335	0.00326	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000333	0.00323	CbGpPWpGaD
Cefotaxime—Vomiting—Vinblastine—breast cancer	0.000319	0.000796	CcSEcCtD
Cefotaxime—Ill-defined disorder—Paclitaxel—breast cancer	0.000319	0.000796	CcSEcCtD
Cefotaxime—Diarrhoea—Goserelin—breast cancer	0.000319	0.000795	CcSEcCtD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000318	0.00309	CbGpPWpGaD
Cefotaxime—Renal impairment—Doxorubicin—breast cancer	0.000317	0.000792	CcSEcCtD
Cefotaxime—Erythema multiforme—Docetaxel—breast cancer	0.000316	0.00079	CcSEcCtD
Cefotaxime—Urticaria—Thiotepa—breast cancer	0.000316	0.000789	CcSEcCtD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000316	0.00307	CbGpPWpGaD
Cefotaxime—Dermatitis bullous—Doxorubicin—breast cancer	0.000316	0.000788	CcSEcCtD
Cefotaxime—Abdominal pain—Thiotepa—breast cancer	0.000315	0.000786	CcSEcCtD
Cefotaxime—Body temperature increased—Thiotepa—breast cancer	0.000315	0.000786	CcSEcCtD
Cefotaxime—Headache—Vinblastine—breast cancer	0.000314	0.000784	CcSEcCtD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000314	0.00306	CbGpPWpGaD
Cefotaxime—Angioedema—Paclitaxel—breast cancer	0.000314	0.000784	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Methotrexate—breast cancer	0.000314	0.000783	CcSEcCtD
Cefotaxime—Vomiting—Tamoxifen—breast cancer	0.00031	0.000773	CcSEcCtD
Cefotaxime—Malaise—Paclitaxel—breast cancer	0.00031	0.000773	CcSEcCtD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.00031	0.00301	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.00031	0.00301	CbGpPWpGaD
Cefotaxime—Leukopenia—Paclitaxel—breast cancer	0.000308	0.000768	CcSEcCtD
Cefotaxime—Rash—Tamoxifen—breast cancer	0.000307	0.000767	CcSEcCtD
Cefotaxime—Hypersensitivity—Vinorelbine—breast cancer	0.000307	0.000767	CcSEcCtD
Cefotaxime—Dermatitis—Tamoxifen—breast cancer	0.000307	0.000766	CcSEcCtD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000306	0.00298	CbGpPWpGaD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000306	0.00298	CbGpPWpGaD
Cefotaxime—Erythema multiforme—Capecitabine—breast cancer	0.000306	0.000764	CcSEcCtD
Cefotaxime—Headache—Tamoxifen—breast cancer	0.000305	0.000762	CcSEcCtD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000304	0.00296	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000304	0.00296	CbGpPWpGaD
Cefotaxime—Vomiting—Melphalan—breast cancer	0.000304	0.000757	CcSEcCtD
Cefotaxime—Rash—Melphalan—breast cancer	0.000301	0.000751	CcSEcCtD
Cefotaxime—Dermatitis—Melphalan—breast cancer	0.000301	0.00075	CcSEcCtD
Cefotaxime—Arrhythmia—Docetaxel—breast cancer	0.000299	0.000746	CcSEcCtD
Cefotaxime—Eosinophilia—Methotrexate—breast cancer	0.000298	0.000744	CcSEcCtD
Cefotaxime—Nausea—Vinblastine—breast cancer	0.000298	0.000744	CcSEcCtD
Cefotaxime—Convulsion—Paclitaxel—breast cancer	0.000298	0.000743	CcSEcCtD
Cefotaxime—Vomiting—Goserelin—breast cancer	0.000296	0.000739	CcSEcCtD
Cefotaxime—Pruritus—Vinorelbine—breast cancer	0.000295	0.000736	CcSEcCtD
Cefotaxime—Pain—Mitoxantrone—breast cancer	0.000294	0.000734	CcSEcCtD
Cefotaxime—Pain—Irinotecan—breast cancer	0.000294	0.000734	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Epirubicin—breast cancer	0.000294	0.000733	CcSEcCtD
Cefotaxime—Rash—Goserelin—breast cancer	0.000294	0.000733	CcSEcCtD
Cefotaxime—Hypersensitivity—Thiotepa—breast cancer	0.000293	0.000732	CcSEcCtD
Cefotaxime—Dermatitis—Goserelin—breast cancer	0.000293	0.000732	CcSEcCtD
Cefotaxime—Headache—Goserelin—breast cancer	0.000292	0.000728	CcSEcCtD
Cefotaxime—Nausea—Tamoxifen—breast cancer	0.00029	0.000723	CcSEcCtD
Cefotaxime—Arrhythmia—Capecitabine—breast cancer	0.000289	0.000722	CcSEcCtD
Cefotaxime—Discomfort—Paclitaxel—breast cancer	0.000289	0.000721	CcSEcCtD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000288	0.00279	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000288	0.00279	CbGpPWpGaD
Cefotaxime—Pain—Gemcitabine—breast cancer	0.000287	0.000715	CcSEcCtD
Cefotaxime—Diarrhoea—Vinorelbine—breast cancer	0.000285	0.000712	CcSEcCtD
Cefotaxime—Nausea—Melphalan—breast cancer	0.000284	0.000707	CcSEcCtD
Cefotaxime—Feeling abnormal—Mitoxantrone—breast cancer	0.000283	0.000707	CcSEcCtD
Cefotaxime—Feeling abnormal—Irinotecan—breast cancer	0.000283	0.000707	CcSEcCtD
Cefotaxime—Neutropenia—Methotrexate—breast cancer	0.000282	0.000703	CcSEcCtD
Cefotaxime—Pruritus—Thiotepa—breast cancer	0.000282	0.000703	CcSEcCtD
Cefotaxime—Pain—Fluorouracil—breast cancer	0.000282	0.000703	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Irinotecan—breast cancer	0.000281	0.000702	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Mitoxantrone—breast cancer	0.000281	0.000702	CcSEcCtD
Cefotaxime—Anaphylactic shock—Paclitaxel—breast cancer	0.000281	0.0007	CcSEcCtD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.00028	0.00272	CbGpPWpGaD
Cefotaxime—Eosinophilia—Epirubicin—breast cancer	0.000279	0.000697	CcSEcCtD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—COX11—breast cancer	0.000278	0.0027	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000278	0.0027	CbGpPWpGaD
Cefotaxime—Nausea—Goserelin—breast cancer	0.000277	0.00069	CcSEcCtD
Cefotaxime—Feeling abnormal—Gemcitabine—breast cancer	0.000276	0.000689	CcSEcCtD
Cefotaxime—Shock—Paclitaxel—breast cancer	0.000276	0.000689	CcSEcCtD
Cefotaxime—Thrombocytopenia—Paclitaxel—breast cancer	0.000275	0.000685	CcSEcCtD
Cefotaxime—Urticaria—Mitoxantrone—breast cancer	0.000273	0.000682	CcSEcCtD
Cefotaxime—Diarrhoea—Thiotepa—breast cancer	0.000273	0.00068	CcSEcCtD
Cefotaxime—Body temperature increased—Mitoxantrone—breast cancer	0.000272	0.000678	CcSEcCtD
Cefotaxime—Abdominal pain—Mitoxantrone—breast cancer	0.000272	0.000678	CcSEcCtD
Cefotaxime—Body temperature increased—Irinotecan—breast cancer	0.000272	0.000678	CcSEcCtD
Cefotaxime—Abdominal pain—Irinotecan—breast cancer	0.000272	0.000678	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Doxorubicin—breast cancer	0.000272	0.000678	CcSEcCtD
Cefotaxime—Feeling abnormal—Fluorouracil—breast cancer	0.000271	0.000677	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Methotrexate—breast cancer	0.000266	0.000665	CcSEcCtD
Cefotaxime—Vomiting—Vinorelbine—breast cancer	0.000265	0.000662	CcSEcCtD
Cefotaxime—Body temperature increased—Gemcitabine—breast cancer	0.000265	0.000661	CcSEcCtD
Cefotaxime—Renal failure—Methotrexate—breast cancer	0.000264	0.000659	CcSEcCtD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000264	0.00256	CbGpPWpGaD
Cefotaxime—Neutropenia—Epirubicin—breast cancer	0.000264	0.000658	CcSEcCtD
Cefotaxime—Rash—Vinorelbine—breast cancer	0.000263	0.000656	CcSEcCtD
Cefotaxime—Dermatitis—Vinorelbine—breast cancer	0.000263	0.000655	CcSEcCtD
Cefotaxime—Ill-defined disorder—Capecitabine—breast cancer	0.000262	0.000653	CcSEcCtD
Cefotaxime—Urticaria—Fluorouracil—breast cancer	0.000262	0.000653	CcSEcCtD
Cefotaxime—Headache—Vinorelbine—breast cancer	0.000261	0.000652	CcSEcCtD
Cefotaxime—Leukopenia—Docetaxel—breast cancer	0.000261	0.000651	CcSEcCtD
Cefotaxime—Body temperature increased—Fluorouracil—breast cancer	0.00026	0.00065	CcSEcCtD
Cefotaxime—Eosinophilia—Doxorubicin—breast cancer	0.000258	0.000645	CcSEcCtD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—COX11—breast cancer	0.000257	0.0025	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000257	0.0025	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000256	0.00249	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000256	0.00249	CbGpPWpGaD
Cefotaxime—Malaise—Capecitabine—breast cancer	0.000254	0.000635	CcSEcCtD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000254	0.00247	CbGpPWpGaD
Cefotaxime—Hypersensitivity—Irinotecan—breast cancer	0.000253	0.000632	CcSEcCtD
Cefotaxime—Hypersensitivity—Mitoxantrone—breast cancer	0.000253	0.000632	CcSEcCtD
Cefotaxime—Vomiting—Thiotepa—breast cancer	0.000253	0.000632	CcSEcCtD
Cefotaxime—Leukopenia—Capecitabine—breast cancer	0.000252	0.00063	CcSEcCtD
Cefotaxime—Convulsion—Docetaxel—breast cancer	0.000252	0.00063	CcSEcCtD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000252	0.00245	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—COX11—breast cancer	0.000252	0.00245	CbGpPWpGaD
Cefotaxime—Rash—Thiotepa—breast cancer	0.000251	0.000627	CcSEcCtD
Cefotaxime—Dermatitis—Thiotepa—breast cancer	0.000251	0.000626	CcSEcCtD
Cefotaxime—Agranulocytosis—Methotrexate—breast cancer	0.000251	0.000626	CcSEcCtD
Cefotaxime—Headache—Thiotepa—breast cancer	0.00025	0.000623	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Epirubicin—breast cancer	0.000249	0.000622	CcSEcCtD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000249	0.00242	CbGpPWpGaD
Cefotaxime—Nausea—Vinorelbine—breast cancer	0.000248	0.000618	CcSEcCtD
Cefotaxime—Renal failure—Epirubicin—breast cancer	0.000247	0.000617	CcSEcCtD
Cefotaxime—Jaundice—Epirubicin—breast cancer	0.000245	0.000612	CcSEcCtD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000245	0.00238	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000245	0.00238	CbGpPWpGaD
Cefotaxime—Neutropenia—Doxorubicin—breast cancer	0.000244	0.000609	CcSEcCtD
Cefotaxime—Hypersensitivity—Fluorouracil—breast cancer	0.000243	0.000606	CcSEcCtD
Cefotaxime—Haemoglobin—Methotrexate—breast cancer	0.000242	0.000605	CcSEcCtD
Cefotaxime—Haemorrhage—Methotrexate—breast cancer	0.000241	0.000602	CcSEcCtD
Cefotaxime—Hepatitis—Methotrexate—breast cancer	0.000241	0.000602	CcSEcCtD
Cefotaxime—Pain—Paclitaxel—breast cancer	0.00024	0.000599	CcSEcCtD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—COX11—breast cancer	0.000238	0.00232	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000238	0.00232	CbGpPWpGaD
Cefotaxime—Anaphylactic shock—Docetaxel—breast cancer	0.000238	0.000593	CcSEcCtD
Cefotaxime—Discomfort—Capecitabine—breast cancer	0.000237	0.000592	CcSEcCtD
Cefotaxime—Pruritus—Gemcitabine—breast cancer	0.000237	0.000591	CcSEcCtD
Cefotaxime—Nausea—Thiotepa—breast cancer	0.000237	0.00059	CcSEcCtD
Cefotaxime—Diarrhoea—Mitoxantrone—breast cancer	0.000235	0.000587	CcSEcCtD
Cefotaxime—Diarrhoea—Irinotecan—breast cancer	0.000235	0.000587	CcSEcCtD
Cefotaxime—SLC22A7—Fluoropyrimidine Activity—TP53—breast cancer	0.000235	0.00228	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000235	0.00228	CbGpPWpGaD
Cefotaxime—Agranulocytosis—Epirubicin—breast cancer	0.000235	0.000585	CcSEcCtD
Cefotaxime—Shock—Docetaxel—breast cancer	0.000234	0.000584	CcSEcCtD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000233	0.00227	CbGpPWpGaD
Cefotaxime—Pruritus—Fluorouracil—breast cancer	0.000233	0.000582	CcSEcCtD
Cefotaxime—Thrombocytopenia—Docetaxel—breast cancer	0.000233	0.000581	CcSEcCtD
Cefotaxime—Feeling abnormal—Paclitaxel—breast cancer	0.000231	0.000577	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Doxorubicin—breast cancer	0.000231	0.000576	CcSEcCtD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000231	0.00224	CbGpPWpGaD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.00023	0.00224	CbGpPWpGaD
Cefotaxime—Gastrointestinal pain—Paclitaxel—breast cancer	0.000229	0.000572	CcSEcCtD
Cefotaxime—Diarrhoea—Gemcitabine—breast cancer	0.000229	0.000572	CcSEcCtD
Cefotaxime—Renal failure—Doxorubicin—breast cancer	0.000229	0.000571	CcSEcCtD
Cefotaxime—Erythema multiforme—Methotrexate—breast cancer	0.000228	0.000569	CcSEcCtD
Cefotaxime—Haemoglobin—Epirubicin—breast cancer	0.000227	0.000566	CcSEcCtD
Cefotaxime—Jaundice—Doxorubicin—breast cancer	0.000227	0.000566	CcSEcCtD
Cefotaxime—Shock—Capecitabine—breast cancer	0.000226	0.000565	CcSEcCtD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000226	0.0022	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000226	0.0022	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000226	0.0022	CbGpPWpGaD
Cefotaxime—Hepatitis—Epirubicin—breast cancer	0.000226	0.000563	CcSEcCtD
Cefotaxime—Haemorrhage—Epirubicin—breast cancer	0.000226	0.000563	CcSEcCtD
Cefotaxime—Diarrhoea—Fluorouracil—breast cancer	0.000225	0.000562	CcSEcCtD
Cefotaxime—Thrombocytopenia—Capecitabine—breast cancer	0.000225	0.000562	CcSEcCtD
Cefotaxime—Urticaria—Paclitaxel—breast cancer	0.000223	0.000556	CcSEcCtD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000222	0.00216	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000222	0.00216	CbGpPWpGaD
Cefotaxime—Abdominal pain—Paclitaxel—breast cancer	0.000222	0.000553	CcSEcCtD
Cefotaxime—Body temperature increased—Paclitaxel—breast cancer	0.000222	0.000553	CcSEcCtD
Cefotaxime—Vomiting—Irinotecan—breast cancer	0.000219	0.000546	CcSEcCtD
Cefotaxime—Vomiting—Mitoxantrone—breast cancer	0.000219	0.000546	CcSEcCtD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000218	0.00212	CbGpPWpGaD
Cefotaxime—Agranulocytosis—Doxorubicin—breast cancer	0.000217	0.000542	CcSEcCtD
Cefotaxime—Rash—Irinotecan—breast cancer	0.000217	0.000541	CcSEcCtD
Cefotaxime—Rash—Mitoxantrone—breast cancer	0.000217	0.000541	CcSEcCtD
Cefotaxime—Dermatitis—Irinotecan—breast cancer	0.000217	0.000541	CcSEcCtD
Cefotaxime—Dermatitis—Mitoxantrone—breast cancer	0.000217	0.000541	CcSEcCtD
Cefotaxime—Headache—Mitoxantrone—breast cancer	0.000215	0.000538	CcSEcCtD
Cefotaxime—Headache—Irinotecan—breast cancer	0.000215	0.000538	CcSEcCtD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000214	0.00208	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000213	0.00207	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000213	0.00207	CbGpPWpGaD
Cefotaxime—Erythema multiforme—Epirubicin—breast cancer	0.000213	0.000533	CcSEcCtD
Cefotaxime—Vomiting—Gemcitabine—breast cancer	0.000213	0.000532	CcSEcCtD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000212	0.00206	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—COX11—breast cancer	0.000212	0.00206	CbGpPWpGaD
Cefotaxime—Rash—Gemcitabine—breast cancer	0.000211	0.000527	CcSEcCtD
Cefotaxime—Dermatitis—Gemcitabine—breast cancer	0.000211	0.000527	CcSEcCtD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000211	0.00205	CbGpPWpGaD
Cefotaxime—Haemoglobin—Doxorubicin—breast cancer	0.00021	0.000524	CcSEcCtD
Cefotaxime—Headache—Gemcitabine—breast cancer	0.00021	0.000524	CcSEcCtD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.00021	0.00204	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.00021	0.00204	CbGpPWpGaD
Cefotaxime—Vomiting—Fluorouracil—breast cancer	0.000209	0.000523	CcSEcCtD
Cefotaxime—Hepatitis—Doxorubicin—breast cancer	0.000209	0.000521	CcSEcCtD
Cefotaxime—Haemorrhage—Doxorubicin—breast cancer	0.000209	0.000521	CcSEcCtD
Cefotaxime—Rash—Fluorouracil—breast cancer	0.000208	0.000518	CcSEcCtD
Cefotaxime—Dermatitis—Fluorouracil—breast cancer	0.000208	0.000518	CcSEcCtD
Cefotaxime—Hypersensitivity—Paclitaxel—breast cancer	0.000207	0.000516	CcSEcCtD
Cefotaxime—Headache—Fluorouracil—breast cancer	0.000206	0.000515	CcSEcCtD
Cefotaxime—Nausea—Irinotecan—breast cancer	0.000204	0.00051	CcSEcCtD
Cefotaxime—Nausea—Mitoxantrone—breast cancer	0.000204	0.00051	CcSEcCtD
Cefotaxime—Pain—Docetaxel—breast cancer	0.000203	0.000507	CcSEcCtD
Cefotaxime—Arrhythmia—Epirubicin—breast cancer	0.000202	0.000503	CcSEcCtD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.0002	0.00194	CbGpPWpGaD
Cefotaxime—Nausea—Gemcitabine—breast cancer	0.000199	0.000497	CcSEcCtD
Cefotaxime—Pruritus—Paclitaxel—breast cancer	0.000198	0.000495	CcSEcCtD
Cefotaxime—Erythema multiforme—Doxorubicin—breast cancer	0.000197	0.000493	CcSEcCtD
Cefotaxime—Pain—Capecitabine—breast cancer	0.000197	0.000491	CcSEcCtD
Cefotaxime—Feeling abnormal—Docetaxel—breast cancer	0.000196	0.000489	CcSEcCtD
Cefotaxime—Nausea—Fluorouracil—breast cancer	0.000196	0.000488	CcSEcCtD
Cefotaxime—Ill-defined disorder—Methotrexate—breast cancer	0.000195	0.000486	CcSEcCtD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000195	0.00189	CbGpPWpGaD
Cefotaxime—Gastrointestinal pain—Docetaxel—breast cancer	0.000194	0.000485	CcSEcCtD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000194	0.00188	CbGpPWpGaD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000193	0.00188	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000193	0.00187	CbGpPWpGaD
Cefotaxime—Diarrhoea—Paclitaxel—breast cancer	0.000192	0.000479	CcSEcCtD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000191	0.00186	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.00019	0.00185	CbGpPWpGaD
Cefotaxime—Feeling abnormal—Capecitabine—breast cancer	0.00019	0.000473	CcSEcCtD
Cefotaxime—Malaise—Methotrexate—breast cancer	0.000189	0.000472	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Capecitabine—breast cancer	0.000188	0.00047	CcSEcCtD
Cefotaxime—Abdominal pain—Docetaxel—breast cancer	0.000188	0.000469	CcSEcCtD
Cefotaxime—Body temperature increased—Docetaxel—breast cancer	0.000188	0.000469	CcSEcCtD
Cefotaxime—Leukopenia—Methotrexate—breast cancer	0.000188	0.000469	CcSEcCtD
Cefotaxime—Arrhythmia—Doxorubicin—breast cancer	0.000187	0.000466	CcSEcCtD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000187	0.00181	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000187	0.00181	CbGpPWpGaD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000185	0.00179	CbGpPWpGaD
Cefotaxime—Urticaria—Capecitabine—breast cancer	0.000183	0.000456	CcSEcCtD
Cefotaxime—Ill-defined disorder—Epirubicin—breast cancer	0.000182	0.000455	CcSEcCtD
Cefotaxime—Body temperature increased—Capecitabine—breast cancer	0.000182	0.000454	CcSEcCtD
Cefotaxime—Abdominal pain—Capecitabine—breast cancer	0.000182	0.000454	CcSEcCtD
Cefotaxime—Convulsion—Methotrexate—breast cancer	0.000182	0.000454	CcSEcCtD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000181	0.00176	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000181	0.00175	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000179	0.00174	CbGpPWpGaD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000178	0.00173	CbGpPWpGaD
Cefotaxime—Vomiting—Paclitaxel—breast cancer	0.000178	0.000445	CcSEcCtD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000178	0.00173	CbGpPWpGaD
Cefotaxime—Malaise—Epirubicin—breast cancer	0.000177	0.000442	CcSEcCtD
Cefotaxime—Rash—Paclitaxel—breast cancer	0.000177	0.000441	CcSEcCtD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—COX11—breast cancer	0.000177	0.00172	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000177	0.00172	CbGpPWpGaD
Cefotaxime—Dermatitis—Paclitaxel—breast cancer	0.000177	0.000441	CcSEcCtD
Cefotaxime—Discomfort—Methotrexate—breast cancer	0.000177	0.000441	CcSEcCtD
Cefotaxime—Leukopenia—Epirubicin—breast cancer	0.000176	0.000439	CcSEcCtD
Cefotaxime—Headache—Paclitaxel—breast cancer	0.000176	0.000438	CcSEcCtD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000175	0.0017	CbGpPWpGaD
Cefotaxime—Hypersensitivity—Docetaxel—breast cancer	0.000175	0.000437	CcSEcCtD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000175	0.0017	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000171	0.00167	CbGpPWpGaD
Cefotaxime—Anaphylactic shock—Methotrexate—breast cancer	0.000171	0.000428	CcSEcCtD
Cefotaxime—Convulsion—Epirubicin—breast cancer	0.00017	0.000425	CcSEcCtD
Cefotaxime—Hypersensitivity—Capecitabine—breast cancer	0.00017	0.000423	CcSEcCtD
Cefotaxime—Ill-defined disorder—Doxorubicin—breast cancer	0.000169	0.000421	CcSEcCtD
Cefotaxime—Pruritus—Docetaxel—breast cancer	0.000168	0.00042	CcSEcCtD
Cefotaxime—Thrombocytopenia—Methotrexate—breast cancer	0.000168	0.000419	CcSEcCtD
Cefotaxime—Nausea—Paclitaxel—breast cancer	0.000167	0.000416	CcSEcCtD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000166	0.00161	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000165	0.00161	CbGpPWpGaD
Cefotaxime—Discomfort—Epirubicin—breast cancer	0.000165	0.000412	CcSEcCtD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000165	0.00161	CbGpPWpGaD
Cefotaxime—Malaise—Doxorubicin—breast cancer	0.000164	0.000409	CcSEcCtD
Cefotaxime—Pruritus—Capecitabine—breast cancer	0.000163	0.000406	CcSEcCtD
Cefotaxime—Leukopenia—Doxorubicin—breast cancer	0.000163	0.000406	CcSEcCtD
Cefotaxime—Diarrhoea—Docetaxel—breast cancer	0.000163	0.000406	CcSEcCtD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000162	0.00158	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000162	0.00157	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000161	0.00156	CbGpPWpGaD
Cefotaxime—Anaphylactic shock—Epirubicin—breast cancer	0.00016	0.0004	CcSEcCtD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000159	0.00154	CbGpPWpGaD
Cefotaxime—Shock—Epirubicin—breast cancer	0.000158	0.000394	CcSEcCtD
Cefotaxime—Convulsion—Doxorubicin—breast cancer	0.000158	0.000393	CcSEcCtD
Cefotaxime—Diarrhoea—Capecitabine—breast cancer	0.000158	0.000393	CcSEcCtD
Cefotaxime—Thrombocytopenia—Epirubicin—breast cancer	0.000157	0.000392	CcSEcCtD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000156	0.00151	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000156	0.00151	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000154	0.00149	CbGpPWpGaD
Cefotaxime—Discomfort—Doxorubicin—breast cancer	0.000153	0.000382	CcSEcCtD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000152	0.00148	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000152	0.00148	CbGpPWpGaD
Cefotaxime—Vomiting—Docetaxel—breast cancer	0.000151	0.000377	CcSEcCtD
Cefotaxime—Rash—Docetaxel—breast cancer	0.00015	0.000374	CcSEcCtD
Cefotaxime—Dermatitis—Docetaxel—breast cancer	0.00015	0.000374	CcSEcCtD
Cefotaxime—Headache—Docetaxel—breast cancer	0.000149	0.000372	CcSEcCtD
Cefotaxime—Anaphylactic shock—Doxorubicin—breast cancer	0.000148	0.00037	CcSEcCtD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000147	0.00143	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000147	0.00143	CbGpPWpGaD
Cefotaxime—Pain—Methotrexate—breast cancer	0.000147	0.000366	CcSEcCtD
Cefotaxime—Vomiting—Capecitabine—breast cancer	0.000146	0.000365	CcSEcCtD
Cefotaxime—Shock—Doxorubicin—breast cancer	0.000146	0.000364	CcSEcCtD
Cefotaxime—Thrombocytopenia—Doxorubicin—breast cancer	0.000145	0.000363	CcSEcCtD
Cefotaxime—Rash—Capecitabine—breast cancer	0.000145	0.000362	CcSEcCtD
Cefotaxime—Dermatitis—Capecitabine—breast cancer	0.000145	0.000362	CcSEcCtD
Cefotaxime—Headache—Capecitabine—breast cancer	0.000144	0.00036	CcSEcCtD
Cefotaxime—Nausea—Docetaxel—breast cancer	0.000141	0.000352	CcSEcCtD
Cefotaxime—Feeling abnormal—Methotrexate—breast cancer	0.000141	0.000352	CcSEcCtD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000141	0.00137	CbGpPWpGaD
Cefotaxime—Gastrointestinal pain—Methotrexate—breast cancer	0.00014	0.00035	CcSEcCtD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000138	0.00134	CbGpPWpGaD
Cefotaxime—Pain—Epirubicin—breast cancer	0.000137	0.000342	CcSEcCtD
Cefotaxime—Nausea—Capecitabine—breast cancer	0.000137	0.000341	CcSEcCtD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000137	0.00133	CbGpPWpGaD
Cefotaxime—Urticaria—Methotrexate—breast cancer	0.000136	0.00034	CcSEcCtD
Cefotaxime—Body temperature increased—Methotrexate—breast cancer	0.000135	0.000338	CcSEcCtD
Cefotaxime—Abdominal pain—Methotrexate—breast cancer	0.000135	0.000338	CcSEcCtD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000134	0.0013	CbGpPWpGaD
Cefotaxime—Feeling abnormal—Epirubicin—breast cancer	0.000132	0.00033	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Epirubicin—breast cancer	0.000131	0.000327	CcSEcCtD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000131	0.00127	CbGpPWpGaD
Cefotaxime—Urticaria—Epirubicin—breast cancer	0.000127	0.000318	CcSEcCtD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000127	0.00124	CbGpPWpGaD
Cefotaxime—Pain—Doxorubicin—breast cancer	0.000127	0.000317	CcSEcCtD
Cefotaxime—Body temperature increased—Epirubicin—breast cancer	0.000127	0.000316	CcSEcCtD
Cefotaxime—Abdominal pain—Epirubicin—breast cancer	0.000127	0.000316	CcSEcCtD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000127	0.00123	CbGpPWpGaD
Cefotaxime—Hypersensitivity—Methotrexate—breast cancer	0.000126	0.000315	CcSEcCtD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000124	0.00121	CbGpPWpGaD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000123	0.00119	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000123	0.00119	CbGpPWpGaD
Cefotaxime—Feeling abnormal—Doxorubicin—breast cancer	0.000122	0.000305	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Doxorubicin—breast cancer	0.000121	0.000303	CcSEcCtD
Cefotaxime—Pruritus—Methotrexate—breast cancer	0.000121	0.000303	CcSEcCtD
Cefotaxime—Hypersensitivity—Epirubicin—breast cancer	0.000118	0.000295	CcSEcCtD
Cefotaxime—Urticaria—Doxorubicin—breast cancer	0.000118	0.000294	CcSEcCtD
Cefotaxime—Body temperature increased—Doxorubicin—breast cancer	0.000117	0.000293	CcSEcCtD
Cefotaxime—Abdominal pain—Doxorubicin—breast cancer	0.000117	0.000293	CcSEcCtD
Cefotaxime—Diarrhoea—Methotrexate—breast cancer	0.000117	0.000293	CcSEcCtD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000117	0.00114	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000116	0.00113	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000115	0.00112	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000115	0.00111	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000114	0.00111	CbGpPWpGaD
Cefotaxime—Pruritus—Epirubicin—breast cancer	0.000113	0.000283	CcSEcCtD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000113	0.00109	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—TFRC—breast cancer	0.000111	0.00108	CbGpPWpGaD
Cefotaxime—Diarrhoea—Epirubicin—breast cancer	0.00011	0.000274	CcSEcCtD
Cefotaxime—Hypersensitivity—Doxorubicin—breast cancer	0.000109	0.000273	CcSEcCtD
Cefotaxime—Vomiting—Methotrexate—breast cancer	0.000109	0.000272	CcSEcCtD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000109	0.00106	CbGpPWpGaD
Cefotaxime—Rash—Methotrexate—breast cancer	0.000108	0.00027	CcSEcCtD
Cefotaxime—Dermatitis—Methotrexate—breast cancer	0.000108	0.000269	CcSEcCtD
Cefotaxime—Headache—Methotrexate—breast cancer	0.000107	0.000268	CcSEcCtD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000106	0.00103	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000106	0.00103	CbGpPWpGaD
Cefotaxime—Pruritus—Doxorubicin—breast cancer	0.000105	0.000262	CcSEcCtD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—TFRC—breast cancer	0.000102	0.000993	CbGpPWpGaD
Cefotaxime—Vomiting—Epirubicin—breast cancer	0.000102	0.000254	CcSEcCtD
Cefotaxime—Nausea—Methotrexate—breast cancer	0.000102	0.000254	CcSEcCtD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000102	0.000987	CbGpPWpGaD
Cefotaxime—Diarrhoea—Doxorubicin—breast cancer	0.000102	0.000253	CcSEcCtD
Cefotaxime—Rash—Epirubicin—breast cancer	0.000101	0.000252	CcSEcCtD
Cefotaxime—Dermatitis—Epirubicin—breast cancer	0.000101	0.000252	CcSEcCtD
Cefotaxime—Headache—Epirubicin—breast cancer	0.0001	0.000251	CcSEcCtD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—TFRC—breast cancer	0.0001	0.000976	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—NCOA2—breast cancer	9.84e-05	0.000956	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—SLC2A1—breast cancer	9.81e-05	0.000953	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—TUBB3—breast cancer	9.69e-05	0.000942	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—NCOA2—breast cancer	9.66e-05	0.000939	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—SLC2A2—breast cancer	9.66e-05	0.000939	CbGpPWpGaD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—ALB—breast cancer	9.53e-05	0.000927	CbGpPWpGaD
Cefotaxime—Nausea—Epirubicin—breast cancer	9.53e-05	0.000238	CcSEcCtD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—TFRC—breast cancer	9.48e-05	0.000922	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—ABCG2—breast cancer	9.46e-05	0.00092	CbGpPWpGaD
Cefotaxime—Vomiting—Doxorubicin—breast cancer	9.43e-05	0.000235	CcSEcCtD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—SLC5A5—breast cancer	9.38e-05	0.000912	CbGpPWpGaD
Cefotaxime—Rash—Doxorubicin—breast cancer	9.36e-05	0.000233	CcSEcCtD
Cefotaxime—Dermatitis—Doxorubicin—breast cancer	9.35e-05	0.000233	CcSEcCtD
Cefotaxime—Headache—Doxorubicin—breast cancer	9.3e-05	0.000232	CcSEcCtD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—SLC5A5—breast cancer	9.22e-05	0.000896	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—NCOA2—breast cancer	9.13e-05	0.000887	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—SLC2A1—breast cancer	9.06e-05	0.000881	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—NCOA1—breast cancer	8.97e-05	0.000872	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—SLC2A1—breast cancer	8.9e-05	0.000865	CbGpPWpGaD
Cefotaxime—Nausea—Doxorubicin—breast cancer	8.81e-05	0.00022	CcSEcCtD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—ALB—breast cancer	8.81e-05	0.000856	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—PLG—breast cancer	8.74e-05	0.00085	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—SLC5A5—breast cancer	8.71e-05	0.000847	CbGpPWpGaD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—ALB—breast cancer	8.65e-05	0.000841	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—TFRC—breast cancer	8.44e-05	0.00082	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—SLC2A1—breast cancer	8.41e-05	0.000818	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—NCOA1—breast cancer	8.29e-05	0.000806	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—ALB—breast cancer	8.18e-05	0.000795	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—NCOA1—breast cancer	8.14e-05	0.000791	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—NCOA2—breast cancer	8.12e-05	0.000789	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—PLG—breast cancer	8.08e-05	0.000785	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—HMOX1—breast cancer	8.07e-05	0.000784	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—SLC2A2—breast cancer	8.06e-05	0.000784	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—PLG—breast cancer	7.93e-05	0.000771	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—ABCG2—breast cancer	7.9e-05	0.000768	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—SLC5A5—breast cancer	7.75e-05	0.000753	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—ABCB1—breast cancer	7.75e-05	0.000753	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—NCOA1—breast cancer	7.69e-05	0.000748	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—PLG—breast cancer	7.5e-05	0.000729	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—SLC2A1—breast cancer	7.48e-05	0.000727	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—HMOX1—breast cancer	7.46e-05	0.000725	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—HMOX1—breast cancer	7.32e-05	0.000712	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—ALB—breast cancer	7.27e-05	0.000707	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—ABCB1—breast cancer	7.16e-05	0.000695	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—TFRC—breast cancer	7.04e-05	0.000684	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—ABCB1—breast cancer	7.03e-05	0.000683	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—HMOX1—breast cancer	6.92e-05	0.000672	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—NCOA1—breast cancer	6.84e-05	0.000665	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—NCOA2—breast cancer	6.78e-05	0.000659	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—PLG—breast cancer	6.67e-05	0.000648	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—ABCB1—breast cancer	6.64e-05	0.000645	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—SLC5A5—breast cancer	6.47e-05	0.000628	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—SLC2A1—breast cancer	6.24e-05	0.000607	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—HMOX1—breast cancer	6.15e-05	0.000598	CbGpPWpGaD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—ALB—breast cancer	6.07e-05	0.00059	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—ABCB1—breast cancer	5.91e-05	0.000574	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—NCOA1—breast cancer	5.71e-05	0.000555	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—PLG—breast cancer	5.57e-05	0.000541	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—HMOX1—breast cancer	5.14e-05	0.000499	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—ABCB1—breast cancer	4.93e-05	0.000479	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—ALB—breast cancer	4.85e-05	0.000471	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—ALB—breast cancer	4.48e-05	0.000435	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—ALB—breast cancer	4.4e-05	0.000427	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—RAF1—breast cancer	4.38e-05	0.000426	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—ALB—breast cancer	4.15e-05	0.000404	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—RAF1—breast cancer	4.05e-05	0.000393	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—RAF1—breast cancer	3.98e-05	0.000386	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—RAF1—breast cancer	3.76e-05	0.000365	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—ALB—breast cancer	3.7e-05	0.000359	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—RAF1—breast cancer	3.34e-05	0.000325	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—ALB—breast cancer	3.08e-05	0.0003	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—RAF1—breast cancer	2.79e-05	0.000271	CbGpPWpGaD
